MARIA AMELIA MURGUI FAUBEL-rekin lankidetzan egindako argitalpenak (8)

2022

  1. Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry

    Cancers, Vol. 14, Núm. 9

2021

  1. Cutaneous Lymphadenoma Is a Distinct Trichoblastoma-like Lymphoepithelial Tumor with Diffuse Androgen Receptor Immunoreactivity, Notch1 Ligand in Reed-Sternberg-like Cells, and Common EGFR Somatic Mutations

    American Journal of Surgical Pathology, Vol. 45, Núm. 10, pp. 1382-1390

2020

  1. Circulating miRNA expression analysis reveals new potential biomarkers for human cutaneous melanoma staging

    Journal of the European Academy of Dermatology and Venereology

  2. Transcriptomic identification of miR-205 target genes potentially involved in metastasis and survival of cutaneous malignant melanoma

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival

    Scientific Reports, Vol. 8, Núm. 1

2015

  1. Deregulation of glyceraldehyde-3-phosphate dehydrogenase expression during tumor progression of human cutaneous melanoma

    Anticancer Research, Vol. 35, Núm. 1, pp. 439-444

2012

  1. CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: New predictive factors of tumor progression in cutaneous malignant melanoma

    Clinical and Experimental Metastasis, Vol. 29, Núm. 6, pp. 625-637

2000

  1. Immunodetection of CD45 epitopes on the surface of Candida albicans cells in culture and infected human tissues

    American Journal of Clinical Pathology, Vol. 113, Núm. 1, pp. 59-63